Miriam Chung
Overview
Explore the profile of Miriam Chung including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
151
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yu S, Deoliveira M, Chung M, Lafayette R
Adv Kidney Dis Health
. 2024 Jul;
31(3):216-222.
PMID: 39004461
Membranoproliferative glomerulonephritis (MPGN) is no longer a disease but a pattern of injury in various diseases. Characterized by electron-dense deposits, mesangial proliferation, and duplication of the glomerular basement membrane, MPGN...
2.
Salem F, Rein J, Yu S, Abramson M, Cravedi P, Chung M
Kidney Int Rep
. 2021 Aug;
6(9):2523-2524.
PMID: 34337193
No abstract available.
3.
Abramson M, Yu S, Campbell K, Chung M, Salem F
Kidney Med
. 2021 Jul;
3(5):860-863.
PMID: 34278290
Here we present the first case of newly diagnosed IgA nephropathy (IgAN) after a SARS-CoV-2 vaccination. A 30-year-old man with no known past medical history presented with gross hematuria and...
4.
Meliambro K, Li X, Salem F, Yi Z, Sun Z, Chan L, et al.
Kidney Med
. 2021 May;
3(4):653-658.
PMID: 33942030
Recent case reports suggest that coronavirus disease 2019 (COVID-19) is associated with collapsing glomerulopathy in African Americans with apolipoprotein L1 gene () risk alleles; however, it is unclear whether disease...
5.
Chan L, Chaudhary K, Saha A, Chauhan K, Vaid A, Baweja M, et al.
medRxiv
. 2020 Jun;
PMID: 32511564
Importance: Preliminary reports indicate that acute kidney injury (AKI) is common in coronavirus disease (COVID)-19 patients and is associated with worse outcomes. AKI in hospitalized COVID-19 patients in the United...
6.
Yamada T, Miyashita H, Rasheed M, Chung M, LiLi , El Salem F, et al.
Am J Med
. 2020 Feb;
133(8):e436-e437.
PMID: 32081655
No abstract available.
7.
Meliambro K, Campbell K, Chung M
Rheum Dis Clin North Am
. 2018 Oct;
44(4):545-560.
PMID: 30274622
Proliferative lupus nephritis requires prompt diagnosis and treatment with immunosuppressive therapy. Cyclophosphamide is the longest studied agent, but mycophenolate mofetil has recently emerged as an efficacious induction and maintenance treatment...
8.
Hartono C, Chung M, Perlman A, Chevalier J, Serur D, Seshan S, et al.
Kidney Int Rep
. 2018 Jul;
3(4):861-866.
PMID: 29988921
Introduction: IgA nephropathy is the most common glomerulonephritis in the world. We conducted a pilot trial (NCT01103778) to test the effect of bortezomib in patients with IgA nephropathy and significant...
9.
Hartono C, Chung M, Kuo S, Seshan S, Muthukumar T
J Nephrol
. 2014 Jan;
27(1):103-6.
PMID: 24430762
Idiopathic membranous nephropathy is a common cause of nephrotic syndrome in adults. The nephrotic syndrome due to idiopathic membranous nephropathy is often resistant to glucocorticosteroids and requires an alkylating agent...
10.
Silberzweig J, Chung M
J Magn Reson Imaging
. 2009 Nov;
30(6):1347-9.
PMID: 19937933
Nephrogenic systemic fibrosis (NSF) has been related to the administration of gadolinium-based contrast agents for magnetic resonance imaging studies in patients with kidney disease. After reviewing the pathophysiology of NSF,...